Peptide-Based Drug Development

With the number of small molecule-based drug candidates in clinical trials and approved drugs for the market decreasing, scientists from the pharmaceutical industry and academia are giving more attention to peptides or other bioactive drugs.Peptide drugs, especially the short synthetic and long-acting ones, are quickly increasing in the global market while advances in such fields as chemical synthesis and peptide formulation having been made in recent decades.